Oncoplastic and organ-preserving resections of mammary gland in cancer
https://doi.org/10.33667/2078-5631-2022-5-42-45
Abstract
The article analyzes the literature data on organ-preserving and oncoplastic breast resections in cancer. Organ-preserving operations were performed in patients with stage I–IIA, comparing the results of treatment with patients after radical mastectomies. Oncoplastic resections are used to achieve good aesthetic results with operable and locally advanced breast cancer, as well as with such an aesthetically unfavorable localization of the tumor node in the mammary gland, which will obviously lead to unsatisfactory cosmetic results with classical organ-preserving surgery. In recent years, the term extreme oncoplastic resection has appeared, in which the indications for performing organ-preserving operations have expanded, namely, with multicentricity, multifocality and a tumor node size of more than 50 mm, it has become possible to perform oncoplastic resections. These operations improve the quality of life in breast cancer patients and are a method of rehabilitation.
About the Authors
E. A. RasskazovaRussian Federation
Rasskazova Elena A., PhD Med, researcher of Dept of Oncology and Reconstructive Plastic Surgery of the Breast and Skin
Moscow
A. D. Zikiryakhodzhaev
Russian Federation
Zikiryakhodzhaev Aziz D., DM Sci (habil.), head of Dept of Oncology and Reconstructive Plastic Surgery of the Breast and Skin, associate professor at Dept of Oncology, Radiotherapy and Reconstructive Surgery, professor at Dept
of Oncology and Radiology
Moscow
A. D. Kaprin
Russian Federation
Kaprin Andrey D., academician of RAS, director, head of Dept of Urology and
Operative Nephrology with a course of oncourology of Medicine Faculty
Moscow
References
1. Kaprin A.D., Starinsky V.V., Shakhzadova A.O. The state of oncological care for the population of Russia in 2019. Moscow, 2020. 239 p.
2. Lagendijk M., Maaren M.C., Saadatmand S., Strobbe L.A et al. Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients. Int J Cancer. 2018 Jan 1; 142 (1): 165–175. DOI: 10.1002/ijc.31034.
3. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233–41.
4. Lombardi A., Pastore E., Maggi S., Stanzani G., Vitale V., Romano C., Bersigotti L., Vecchione A., Amanti C. Positive margins (R1) risk factors in breast cancer conservative surgery. Breast Cancer: Targets and Therapy Volume 11: 2019: 243–248.
5. Wimmer K., Bolliger M., Bago-Horvath Z., Steger G., Kauer-Dorner D., Helfgott R., Gruber C., Moinfar F., Mittlböck M., Fitzal F. Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival. Ann Surg Oncol 2020 May; 27 (5): 1700–1707.
6. Pahmeyer C., Schablack A., Ratiu D., Thangarajah F., Ludwig S, Gruettner B., Mallmann P., Malter W., Warm M., Eichler Ch. Occurrence of Residual Cancer Within Re-Excisions After Subcutaneous Mastectomy of Invasive Breast Cancer and Ductal Carcinoma in Situ–A Retrospective Analysis In Vivo Jul-Aug 2020; 34 (4): 2015–2019.
7. Schwartz G. F., Veronesi U., Clough K.B., et al. Consensus conference on breast conservation. J Am Coll Surg. 2006; 203: 198–207.
8. Egorov Yu.S., Dzotzoev A.K. Oncoplastic resection in surgical treatment of breast cancer. Issues of reconstructive and plastic surgery. 2016; Vol. 19, No. 2 (57): 49–56.
9. Kirillova E. L., Sidorov M.A. Oncoplastic approaches in breast cancer surgery. Kremlin Medicine. Clinical Bulletin. 2015. No. 3: 86–91.
10. Ryabchikov D.A., Vorotnikov I.K., Dudina I.A., Kazakov A.M., Denchik D.A. Topical issues of oncoplastic organ-preserving breast cancer surgery. Bulletin of Surgery n.a. I.I. Grekov. 2019; 178 (5): 36–46.
11. Niinikoski L., Leidenius M., Vaara P., Voynov A., Heikkilä P, Mattson J., Meretoja T. Resection margins and local recurrences in breast cancer: Comparison between conventional and oncoplastic breast conserving surgery. Eur J Surg Oncol. 2019 Jun; 45 (6): 976–982.
12. Behluli I., Le Renard P.-E., Rozwag K., Oppelt P., Kaufmann A., Schneider A. Oncoplastic breast surgery versus conventional breast-conserving surgery: a comparative retrospective study. ANZ J Surg. 2019 Oct; 89 (10): 1236–1241.
13. Fitzal F., Bolliger M., Dunkler D. et al. Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC‑01/ iTOP2 Study. Ann Surg Oncol (2021). https://doi.org/10.1245/s10434–021–10809–1
14. Shah C.V.V., Sayles H., Recht A., Vicini F. Appropriate margins for breast conserving surgery in patients with early-stage breast cancer: a meta-analysis. Cancer Research 2018;78 (4 Suppl): GS5–01.
15. Silverstein M. J., Savalia N., Khan S., Ryan J. Extreme oncoplasty: breast conservation for patients who need mastectomy. Breast J. 2015; 21 (1): 52–59.
16. Savioli F., Seth S., Morrow E., Doughty J., Stallard Sh., Malyon A., Romics L. Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer. Breast Cancer (Dove Med Press) 2021 May 25; 13: 353–359. DOI: 10.2147/BCTT.S296242.
17. Koppiker Ch.B., Noor A.U., Dixit S., Busheri L., Sharan G., Dhar U., Allampati H.K., Nare S. Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer. Int J Breast Cancer. 2019 Feb 20; 2019: 4262–589. DOI: 10.1155/2019/4262589
Review
For citations:
Rasskazova E.A., Zikiryakhodzhaev A.D., Kaprin A.D. Oncoplastic and organ-preserving resections of mammary gland in cancer. Medical alphabet. 2022;1(5):42-45. (In Russ.) https://doi.org/10.33667/2078-5631-2022-5-42-45